The selective inhibitor of c-FOS/activator protein-1 (AP-1, a redox-sensitive transcription factor) inhibited proinflammatory cytokines and improved the survival of lipopolysaccharide-induced AKI (49). The gene discussed is FOS; the disease is acute kidney injury.